Focus Therapy Areas: Oncology, Haematology, Endocrinology, Immunology, Neuroscience
Specialist Expertise: Cell & Gene Therapy, Partnering, Beyond-the-Pill and Digital Services
Education: PhD in Investigative Medicine Imperial College London, BA (Hons) in Biological Sciences University of Cambridge
What is your focus at Eradigm?
My focus is on leading high-impact Strategic and Competitive Intelligence projects, to inform and guide commercial strategy at both an asset and a cross-portfolio level. My aim is to drive meaningful conversations for our clients, which ultimately shape the future of healthcare.
Who do you work with?
I work predominantly with senior executives, global brand leads and Competitive Intelligence leads across top 20 biopharma companies.
What is your specialist expertise, and what types of projects do you work on?
My work spans specialist technologies such as cell and gene therapies, as well as cross-portfolio projects which shape overarching corporate strategy. My broad portfolio includes global CI monitoring in oncology, optimising launch via service offerings in immunology, and redefining cross-portfolio business development strategies.
What did you do before Eradigm?
Before joining Eradigm, I completed my PhD in Investigative Medicine, where I led development of a novel therapeutic for Type 2 Diabetes and Obesity from candidate selection to Phase 1 trials. I also worked at GLG, where I developed strong skills in primary research, and gained commercial experience with Amgen.
What are your passions outside of work?
Outside of work, I am a theatre aficionado and am an avid reader/watcher of all things Chekov, Beckett and Pinter. I am also a keen traveller and love exploring new cultures and cuisines.